Galvez-Sánchez Carmen M, Montoro Casandra I, Moreno-Padilla María, Reyes Del Paso Gustavo A, de la Coba Pablo
Department of Psychology, University of Jaén, 23071 Jaén, Spain.
J Clin Med. 2021 Jun 19;10(12):2706. doi: 10.3390/jcm10122706.
Acceptance and commitment therapy (ACT) is considered by the American Psychological Association as an evidence-based treatment for a variety of disorders, including chronic pain. The main objective of the present systematic review was to determine the effectiveness of ACT in patients with central pain sensitization syndromes (CPSS).
This systematic review was conducted according to the guidelines of the Cochrane Collaboration and PRISMA statements. The protocol was registered in advance in the Prospective Register of Systematic Reviews (PROSPERO) international database. The selected articles were evaluated using the Cochrane risk of bias (ROB) assessment tool. The PubMed, Scopus, and Web of Science databases were searched.
The literature search identified 21 studies (including investigations of fibromyalgia syndrome, irritable bowel syndrome, and migraine) eligible for the systematic review. There were no studies regarding the effectiveness of ACT for chronic tension-type headache (CTTH), interstitial cystitis (IC), or temporomandibular disorder (TMD). The evaluation of ROB showed that 12 of the selected studies were of low quality, 5 were of moderate quality, and 4 were high quality. ACT reduces some clinical symptoms, such as anxiety, depression, and pain. This positive effect of ACT might be mediated by pain acceptance, psychological flexibility, optimism, self-efficacy, or adherence to values. ACT showed better results in comparison to non-intervention (e.g., "waiting list") conditions, as well as pharmacological and psychoeducational interventions. It is not entirely clear whether extended ACT treatments are more advantageous than briefer interventions.
There are few studies about the effectiveness of ACT on CPSS. However, ACT seems to reduce subjective CPSS symptoms and improve the health-related quality of life of these patients. The absence of studies on the effectiveness of ACT in CTTH, IC, and TMD, indicate the pressing need for further ACT studies in these CPSS.
美国心理学会认为接纳与承诺疗法(ACT)是针对包括慢性疼痛在内的多种疾病的循证治疗方法。本系统评价的主要目的是确定ACT对中枢性疼痛敏化综合征(CPSS)患者的有效性。
本系统评价按照Cochrane协作网和PRISMA声明的指南进行。该方案已预先在国际系统评价前瞻性注册库(PROSPERO)中注册。使用Cochrane偏倚风险(ROB)评估工具对所选文章进行评估。检索了PubMed、Scopus和科学引文索引数据库。
文献检索确定了21项符合系统评价条件的研究(包括纤维肌痛综合征、肠易激综合征和偏头痛的研究)。没有关于ACT对慢性紧张型头痛(CTTH)、间质性膀胱炎(IC)或颞下颌关节紊乱(TMD)有效性的研究。ROB评估显示,所选研究中有12项质量低,5项质量中等,4项质量高。ACT可减轻一些临床症状,如焦虑、抑郁和疼痛。ACT的这种积极作用可能是通过疼痛接纳、心理灵活性、乐观主义、自我效能感或对价值观的坚持来介导的。与非干预(如“等待名单”)条件以及药物和心理教育干预相比,ACT显示出更好的效果。目前尚不完全清楚延长ACT治疗是否比短期干预更具优势。
关于ACT对CPSS有效性的研究较少。然而,ACT似乎能减轻CPSS的主观症状,并改善这些患者的健康相关生活质量。缺乏关于ACT对CTTH、IC和TMD有效性的研究,表明迫切需要在这些CPSS中进一步开展ACT研究。